当前位置:首页 - 行情中心 - 索宝蛋白(603231) - 财务分析 - 现金流量表

索宝蛋白

(603231)

  

流通市值:18.94亿  总市值:34.12亿
流通股本:1.06亿   总股本:1.91亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,906,630,887.781,269,190,681.3774,628,905.1401,336,324.32
  收到的税费返还59,397,996.951,398,315.3934,268,039.7914,509,292.95
  收到其他与经营活动有关的现金62,996,329.1344,590,078.929,614,465.748,325,603.34
  经营活动现金流入小计2,029,025,213.811,365,179,075.61818,511,410.63424,171,220.61
  购买商品、接受劳务支付的现金1,433,660,400.791,035,263,652.11676,267,894.88409,894,840.83
  支付给职工以及为职工支付的现金124,445,460.1789,272,952.1562,303,117.6537,015,666.27
  支付的各项税费53,725,012.7241,434,208.2227,343,901.1313,977,278.69
  支付其他与经营活动有关的现金106,088,364.970,183,473.0623,787,757.3119,167,854.76
  经营活动现金流出小计1,717,919,238.581,236,154,285.54789,702,670.97480,055,640.55
  经营活动产生的现金流量净额311,105,975.23129,024,790.0728,808,739.66-55,884,419.94
二、投资活动产生的现金流量:
  取得投资收益收到的现金12,413,098.057,615,455.434,139,015.566,930,144.12
  处置固定资产、无形资产和其他长期资产收回的现金净额213,778.89187,210187,011.78-
  收到的其他与投资活动有关的现金2,767,080,0001,902,780,0001,274,380,000783,180,000
  投资活动现金流入小计2,779,706,876.941,910,582,665.431,278,706,027.34790,110,144.12
  购建固定资产、无形资产和其他长期资产支付的现金189,990,622.9689,868,075.2954,962,134.1737,813,968.06
  支付其他与投资活动有关的现金2,923,509,444.442,058,809,444.441,260,909,444.44893,709,444.44
  投资活动现金流出小计3,113,500,067.42,148,677,519.731,315,871,578.61931,523,412.5
  投资活动产生的现金流量净额-333,793,190.46-238,094,854.3-37,165,551.27-141,413,268.38
三、筹资活动产生的现金流量:
  取得借款收到的现金47,548,00047,548,00023,774,00023,774,000
  筹资活动现金流入小计47,548,00047,548,00023,774,00023,774,000
  偿还债务支付的现金47,548,00047,548,00023,774,00023,774,000
  分配股利、利润或偿付利息支付的现金57,493,061.5357,494,904.0157,498,564.98120,489.68
  支付其他与筹资活动有关的现金1,532,821.031,292,821.031,052,821.03-
  筹资活动现金流出小计106,573,882.56106,335,725.0482,325,386.0123,894,489.68
  筹资活动产生的现金流量净额-59,025,882.56-58,787,725.04-58,551,386.01-120,489.68
四、汇率变动对现金及现金等价物的影响333,651.317,013,825.837,497,128.961,740,972.57
五、现金及现金等价物净增加额-81,379,446.48-160,843,963.44-59,411,068.66-195,677,205.43
  加:期初现金及现金等价物余额320,021,347.41320,021,347.41320,021,347.41320,021,347.41
  期末现金及现金等价物余额238,641,900.93159,177,383.97260,610,278.75124,344,141.98
补充资料:
  净利润189,716,351.28-97,432,394.07-
  资产减值准备2,347,992.39--16,626.41-
  固定资产和投资性房地产折旧74,641,553.79-32,652,700.05-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧74,641,553.79-32,652,700.05-
  无形资产摊销2,462,239.81-1,031,264.7-
  处置固定资产、无形资产和其他长期资产的损失-30,270.73-499,658.78-
  固定资产报废损失3,609,819.03-224,051.15-
  公允价值变动损失-5,275,163.24--2,926,444.79-
  财务费用80,950.04-77,609.38-
  投资损失-2,838,359.07--702,493.6-
  递延所得税-212,967.31--326,878.29-
  其中:递延所得税资产减少777,637.15-19,337.71-
    递延所得税负债增加-990,604.46--346,216-
  存货的减少35,564,417.58--6,473,890.82-
  经营性应收项目的减少-28,268,121.51--18,782,796.71-
  经营性应付项目的增加37,495,123.03--67,320,046.24-
  其他-310,592.1--7,497,128.96-
  现金的期末余额238,641,900.93-260,610,278.75-
  减:现金的期初余额320,021,347.41-320,021,347.41-
  现金及现金等价物的净增加额-81,379,446.48--59,411,068.66-
公告日期2026-04-242025-10-312025-08-282025-04-25
审计意见(境内)标准无保留意见
TOP↑